INTRALIPID

This brand name is authorized in Austria, Canada, Cyprus, Estonia, Spain, Hong Kong, Ireland, Lithuania, Malta, New Zealand, Poland, Romania, Singapore, United Kingdom, United States

Active ingredients

The drug INTRALIPID contains one active pharmaceutical ingredient (API):

1 Soybean oil, refined UNII 241ATL177A - SOYBEAN OIL

Read about Soybean oil, refined

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B05BA02	Fat emulsions	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05B I.V. solutions → B05BA Solutions for parenteral nutrition
Discover more medicines within B05BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02065673
Country: EE	Ravimiamet	Identifier(s): 1009280, 1066687, 1066698, 1776809
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 43165, 61534
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 308369, 308370, 308372, 308374, 308375, 76275, 76279, 76283, 76287, 76291
Country: HK	Department of Health Drug Office	Identifier(s): 35420, 35421
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1008223, 1008224, 1008225, 1008226, 1011905, 1034424, 1034425, 1086407
Country: MT	Medicines Authority	Identifier(s): MA1123/02001
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 1241, 1242, 1243
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100031894, 100031902
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W57683010, W57683011, W57683012, W57683013
Country: SG	Health Sciences Authority	Identifier(s): 05269P
Country: US	FDA, National Drug Code	Identifier(s): 0338-0518, 0338-0519, 0338-0520, 51662-1333